These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 28513288

  • 1. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
    Li W, Wang J, Ge L, Shan J, Zhang C, Liu J.
    Clin Exp Hypertens; 2017; 39(4):382-387. PubMed ID: 28513288
    [Abstract] [Full Text] [Related]

  • 2. Association of plasma growth arrest-specific protein 6 (Gas6) concentrations with albuminuria in patients with type 2 diabetes.
    Erek-Toprak A, Bingol-Ozakpinar O, Karaca Z, Cikrikcioglu MA, Hursitoglu M, Uras AR, Adeli K, Uras F.
    Ren Fail; 2014 Jun; 36(5):737-42. PubMed ID: 24512357
    [Abstract] [Full Text] [Related]

  • 3. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
    Salem NA, El Helaly RM, Ali IM, Ebrahim HAA, Alayooti MM, El Domiaty HA, Aboelenin HM.
    Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
    [Abstract] [Full Text] [Related]

  • 4. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z, Xu Y, Liu X, Nie Y, Zhao Z.
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [Abstract] [Full Text] [Related]

  • 5. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.
    Lv C, Zhou YH, Wu C, Shao Y, Lu CL, Wang QY.
    Diabetes Metab Res Rev; 2015 Oct; 31(7):717-24. PubMed ID: 25952368
    [Abstract] [Full Text] [Related]

  • 6. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes.
    Jeon YK, Kim MR, Huh JE, Mok JY, Song SH, Kim SS, Kim BH, Lee SH, Kim YK, Kim IJ.
    J Korean Med Sci; 2011 Feb; 26(2):258-63. PubMed ID: 21286018
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
    Ye H, Bai X, Gao H, Li L, Wu C, Sun X, Zhang C, Shen Y, Zhang J, Lu Z.
    J Diabetes Complications; 2014 Feb; 28(1):96-100. PubMed ID: 24075693
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plasma type IV collagen levels as a potential biomarker for early detection of nephropathy in diabetes mellitus patients.
    Atita FA, El-Hagrasy HA, Hassan MM, Esawy HS.
    Egypt J Immunol; 2024 Jul; 31(3):150-160. PubMed ID: 38996049
    [Abstract] [Full Text] [Related]

  • 14. The Clinical Value of Serum Adropin Level in Early Detection of Diabetic Nephropathy.
    Es-Haghi A, Al-Abyadh T, Mehrad-Majd H.
    Kidney Blood Press Res; 2021 Jul; 46(6):734-740. PubMed ID: 34644709
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum chromogranin A correlated with albuminuria in diabetic patients and is associated with early diabetic nephropathy.
    Yu H, Wang H, Su X, Cao A, Yao X, Wang Y, Zhu B, Wang H, Fang J.
    BMC Nephrol; 2022 Jan 21; 23(1):41. PubMed ID: 35062888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.